Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 4/20 | 0.57 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | THRA | P10827 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345353 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL15233352 | 0.94 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL23421038 | 0.94 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL23421037 | 0.94 | ZDHHC20 (0.54) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL23421424 | 0.94 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL23421169 | 0.94 | ZDHHC20 (0.64) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL19610469 | 0.94 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL15233351 | 0.92 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL6510490 | 0.92 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2CA12CA9CA1 | |
| SCHEMBL12200652 | 0.92 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2CA12CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080145405-A1 | Providing a clean device comprising a porous polymer core containing an ocular drug in it cavities and covered by a polymer shell permeable for passage of the drug(s); subjecting the device to a supercritical fluid to remove contaminants; sustained release; grafting or injection; vision defects | BAUSCH & LOMB INCORPORATED | 2008-06-19 | — | — | US | claimed |
| US-20070218104-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | BAUSCH & LOMB INCORPORATION | 2007-09-20 | — | — | US | claimed |
| US-20070218103-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | BAUSCH & LOMB INCORPORATED | 2007-09-20 | — | — | US | claimed |
| US-11339288-B2 | Photocurable composition and coating layer including cured product thereof | LG CHEM, LTD. | 2022-05-24 | — | — | US | disclosed |
| WO-2022059935-A1 | METHOD FOR PREPARING COSMETIC COMPOSITION COMPRISING NON-AQUEOUS DISPERSION, AND COSMETIC COMPOSITION PREPARED BY SAME METHOD | 주식회사 엘지생활건강 | 2022-03-24 | — | — | WO | disclosed |
| CN-113573685-A | Nonaqueous dispersion liquid, method for producing same, and cosmetic composition containing same | 株式会社LG生活健康 | 2021-10-29 | — | — | CN | disclosed |
| US-20200339809-A1 | Photocurable Composition And Coating Layer Including Cured Product Thereof | LG CHEM, LTD. (KR) | 2020-10-29 | — | — | US | disclosed |
| WO-2020189870-A1 | NON-AQUEOUS DISPERSION, PREPARATION METHOD THEREFOR, AND COSMETIC COMPOSITION COMPRISING SAME | 주식회사 엘지생활건강 | 2020-09-24 | — | — | WO | disclosed |
| US-10280319-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2019-05-07 | — | — | US | disclosed |
| US-20170137644-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | MORITA MITSUNOBU (JP) | 2017-05-18 | — | — | US | disclosed |
| US-20150031106-A1 | HCV PROTEASE INHIBITORS AND USES THEREOF | CELGENE AVILOMICS RESEARCH, INC. (US) | 2015-01-29 | — | — | US | disclosed |
| US-8524116-B2 | Multilayer sheet containing optically anisotropic layer containing liquid crystal compound and cellulose ester with polymer | FUJIFILM CORPORATION (JP) | 2013-09-03 | — | — | US | disclosed |
| US-20130211028-A1 | ACRYLIC POLYMER FOR USE IN PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR TOUCH SCREEN PANEL | DAIDO CHEMICAL CORPORATION (JP) | 2013-08-15 | — | — | US | disclosed |
| EP-2607443-A1 | ACRYLIC POLYMER FOR USE IN PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR TOUCH PANEL | Daido Chemical Corporation (JP) | 2013-06-26 | — | — | EP | disclosed |
| WO-2008108859-A1 | BIOCOMPATIBLE, SURFACE MODIFIED MATERIALS | BAUSCH & LOMB INCORPORATED (US) | 2008-09-12 | — | — | WO | disclosed |
| US-20080147021-A1 | DRUG DELIVERY DEVICES | BAUSCH & LOMB INCORPORATED | 2008-06-19 | — | — | US | disclosed |
| US-20080145405-A1 | Providing a clean device comprising a porous polymer core containing an ocular drug in it cavities and covered by a polymer shell permeable for passage of the drug(s); subjecting the device to a supercritical fluid to remove contaminants; sustained release; grafting or injection; vision defects | BAUSCH & LOMB INCORPORATED | 2008-06-19 | — | — | US | disclosed |
| US-20080002146-A1 | BIOCOMPATIBLE, SURFACE MODIFIED MATERIALS | BAUSCH & LOMB INCORPORATED | 2008-01-03 | — | — | US | disclosed |
| US-20070218104-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | BAUSCH & LOMB INCORPORATION | 2007-09-20 | — | — | US | disclosed |
| US-20070218103-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | BAUSCH & LOMB INCORPORATED | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070218104-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | IDUA, ACMSD, MLEC | ZDHHC20 4434/4885ZDHHC2 4424/4885CA12 3516/4885 |
| US-10280319-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | CDKN1A, MAPK9, SFRP1 | ZDHHC20 4289/4885ZDHHC2 4661/4885CA12 2546/4885 |
| US-20150031106-A1 | HCV PROTEASE INHIBITORS AND USES THEREOF | PEPD, CTRL, CTSC | ZDHHC20 690/4885ZDHHC2 886/4885CA12 2068/4885 |
| US-20070218103-A1 | Rate controlled release of a pharmaceutical agent in a biodegradable device | IDUA, APEH, PAM | ZDHHC20 4467/4885ZDHHC2 4439/4885CA12 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.